Perspective Therapeutics: JonesTrading cuts target price to $6 from $18
CATX•JonesTrading cut its target price for Perspective Therapeutics to $6 from $18.
Related News
OGE Energy raises 2026 EPS guidance to $2.62-$2.68 on favorable weather
OGE•
Valion Bio reports positive Entolimod safety results in mouse study
VBIO•
Global stocks get AI boost ahead of packed 48 hours
SPY•
Blackbaud Q3 2026 non-GAAP diluted EPS rises 24% year over year to $1.36
BLKB•
CH Robinson Q3 EPS $1.67
CHRW•